NCT01966497

Observational Study of Patients Older Than 60 Years With Acute Myeloblastic Leukemia

Observational Study of Patients Older Than 60 Years and With Acute Myeloblastic Leukemia Who Are Administered Standard Chemotherapy Based on Idarubicine-cytarabine

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 1,000 (estimated)
• Sponsor: Assistance Publique - Hôpitaux de Paris · Academic / Other
• Sex: All
• Age: 60 Years
• Healthy volunteers: Not accepted

Summary

The main objective of this observational survey is to estimate the incidence, the typology, and the evolution of patients with acute myelobalstic leukemia, aged more than 60 years old. In this age group (aged more than 60y), three groups of patients with very different response rates and late outcome can be delineated with specific standard chemotherapy.

Conditions

• Acute Myeloblastic Leukemia
• Aged Higher Than 60 Years Old

Timeline

• Start date: 2012-11-01
• Primary completion: 2019-04-01
• Completion: 2019-11-01
• First posted: 2013-10-21
• Last updated: 2017-11-20

Locations

1 site across 1 country: France